Amed Ouattara, Ph.D. - Publications

Affiliations: 
2012 Epidemiology and Preventive Medicine University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Epidemiology, Molecular Biology, Parasitology Biology

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shah Z, Naung MT, Moser KA, Adams M, Buchwald AG, Dwivedi A, Ouattara A, Seydel KB, Mathanga DP, Barry AE, Serre D, Laufer MK, Silva JC, Takala-Harrison S. Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria. Plos Genetics. 17: e1009576. PMID 34033654 DOI: 10.1371/journal.pgen.1009576  0.4
2020 Friedman-Klabanoff DJ, Travassos MA, Ifeonu OO, Agrawal S, Ouattara A, Pike A, Bailey JA, Adams M, Coulibaly D, Lyke KE, Laurens MB, Takala-Harrison S, Kouriba B, Kone AK, Doumbo OK, et al. Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population. The Journal of Infectious Diseases. PMID 32992328 DOI: 10.1093/infdis/jiaa611  0.4
2020 Ouattara A, Niangaly A, Adams M, Coulibaly D, Kone AK, Traore K, Laurens MB, Tolo Y, Kouriba B, Diallo DA, Doumbo OK, Plowe CV, Djimdé A, Thera MA, Laufer MK, et al. Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02 vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants. Vaccine. PMID 32571720 DOI: 10.1016/J.Vaccine.2020.06.035  0.4
2020 Bailey JA, Berry AA, Travassos MA, Ouattara A, Boudova S, Dotsey EY, Pike A, Jacob CG, Adams M, Tan JC, Bannen RM, Patel JJ, Pablo J, Nakajima R, Jasinskas A, et al. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. Scientific Reports. 10: 3952. PMID 32127565 DOI: 10.1038/S41598-020-60551-Z  0.4
2020 Moser KA, Drábek EF, Dwivedi A, Stucke EM, Crabtree J, Dara A, Shah Z, Adams M, Li T, Rodrigues PT, Koren S, Phillippy AM, Munro JB, Ouattara A, Sparklin BC, et al. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Medicine. 12: 6. PMID 31915075 DOI: 10.1186/S13073-019-0708-9  0.4
2019 Stucke EM, Niangaly A, Berry AA, Bailey JA, Coulibaly D, Ouattara A, Lyke KE, Laurens MB, Dara A, Adams M, Pablo J, Jasinskas A, Nakajima R, Zhou AE, Agrawal S, et al. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag. Malaria Journal. 18: 273. PMID 31409360 DOI: 10.1186/S12936-019-2905-9  0.4
2019 Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Agrawal S, Stucke EM, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Adams M, Takala-Harrison S, Pablo J, Jasinskas A, et al. Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure. Msphere. 4. PMID 30894432 DOI: 10.1128/mSphere.00097-19  0.4
2019 Berry AA, Gottlieb ER, Kouriba B, Diarra I, Thera MA, Dutta S, Coulibaly D, Ouattara A, Niangaly A, Kone AK, Traore K, Tolo Y, Mishcherkin V, Soisson L, Diggs CL, et al. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02. Malaria Journal. 18: 13. PMID 30658710 DOI: 10.1186/S12936-019-2637-X  0.4
2018 Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan. Malaria Journal. 17: 471. PMID 30558587 DOI: 10.1186/S12936-018-2620-Y  0.4
2018 Ouattara A, Tran TM, Doumbo S, Matthew A, Agrawal S, Niangaly A, Nelson-Owens S, Doumtabé D, Tolo Y, Ongoiba A, Takala-Harrison S, Traoré B, Silva JC, Crompton PD, Doumbo OK, et al. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Reticulocyte-Binding Protein Homologue-5 in Kalifabougou, Mali. The American Journal of Tropical Medicine and Hygiene. PMID 29848401 DOI: 10.4269/Ajtmh.17-0737  0.4
2018 Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima R, Berry AA, Adams M, Jacob CG, Pike A, Takala-Harrison S, et al. Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets. Scientific Reports. 8: 6281. PMID 29674705 DOI: 10.1038/S41598-018-24462-4  0.4
2017 Zainabadi K, Adams M, Han ZY, Lwin HW, Han KT, Ouattara A, Thura S, Plowe CV, Nyunt MM. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections. Malaria Journal. 16: 377. PMID 28923054 DOI: 10.1186/S12936-017-2025-3  0.4
2017 Boudová S, Walldorf JA, Bailey JA, Divala T, Mungwira R, Mawindo P, Pablo J, Jasinskas A, Nakajima R, Ouattara A, Adams M, Felgner PL, Plowe CV, Travassos MA, Laufer MK. Mother-newborn pairs in Malawi have similar antibody repertoire to diverse malaria antigens. Clinical and Vaccine Immunology : Cvi. PMID 28835359 DOI: 10.1128/Cvi.00136-17  0.4
2017 Dama S, Niangaly H, Ouattara A, Sagara I, Sissoko S, Traore OB, Bamadio A, Dara N, Djimde M, Alhousseini ML, Goita S, Maiga H, Dara A, Doumbo OK, Djimde AA. Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali. Malaria Journal. 16: 59. PMID 28148267 DOI: 10.1186/S12936-017-1700-8  0.4
2016 Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Takala-Harrison S, Berry AA, Doumbo OK, Plowe CV. Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications. Plos One. 11: e0148240. PMID 26820850 DOI: 10.1371/journal.pone.0148240  0.4
2015 Ouattara A, Barry AE, Dutta S, Remarque EJ, Beeson JG, Plowe CV. Designing malaria vaccines to circumvent antigen variability. Vaccine. PMID 26475447 DOI: 10.1016/J.Vaccine.2015.09.110  0.4
2015 Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, Coulibaly D, Thera MA, Diallo N, Dara A, Sagara I, Gil JP, Bjorkman A, Takala-Harrison S, Doumbo OK, et al. Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali. The American Journal of Tropical Medicine and Hygiene. 92: 1202-6. PMID 25918205 DOI: 10.4269/Ajtmh.14-0605  0.4
2015 Travassos MA, Coulibaly D, Bailey JA, Niangaly A, Adams M, Nyunt MM, Ouattara A, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima R, Berry AA, Takala-Harrison S, Kone AK, et al. Differential Recognition of Terminal Extracellular Plasmodium falciparum VAR2CSA Domains by Sera from Multigravid, Malaria-Exposed Malian Women. The American Journal of Tropical Medicine and Hygiene. 92: 1190-4. PMID 25918203 DOI: 10.4269/Ajtmh.14-0524  0.4
2015 Ouattara A, Laurens MB. Vaccines against malaria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 930-6. PMID 25452593 DOI: 10.1093/Cid/Ciu954  0.4
2015 Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, et al. Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. The American Journal of Tropical Medicine and Hygiene. 92: 9-12. PMID 25294612 DOI: 10.4269/Ajtmh.14-0140  0.4
2014 Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Takala-Harrison S, Berry AA, Doumbo OK, Plowe CV. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications. Plos One. 9: e101783. PMID 24992338 DOI: 10.1371/Journal.Pone.0101783  0.4
2013 Laurens MB, Thera MA, Coulibaly D, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, et al. Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial. Plos One. 8: e79323. PMID 24260195 DOI: 10.1371/Journal.Pone.0079323  0.4
2013 Khattak AA, Venkatesan M, Khatoon L, Ouattara A, Kenefic LJ, Nadeem MF, Nighat F, Malik SA, Plowe CV. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan. Malaria Journal. 12: 310. PMID 24007534 DOI: 10.1186/1475-2875-12-310  0.4
2013 Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Laurens MB, Pablo J, Jasinskas A, Nakajima-Sasaki R, Berry AA, Takala-Harrison S, Kouriba B, Rowe JA, Lyke KE, Doumbo OK, et al. Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults. The Journal of Infectious Diseases. 208: 1514-9. PMID 23901079 DOI: 10.1093/Infdis/Jit339  0.4
2013 Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, et al. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. The Journal of Infectious Diseases. 207: 511-9. PMID 23204168 DOI: 10.1093/Infdis/Jis709  0.4
2012 Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, Diallo M, Sagara I, Masinde GL, Doumbo SN, Dolo A, Tounkara A, Traoré I, Krogstad DJ. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. The American Journal of Tropical Medicine and Hygiene. 86: 194-8. PMID 22302847 DOI: 10.4269/Ajtmh.2012.10-0665  0.4
2011 Ouattara A, Doumbo S, Saye R, Beavogui AH, Traoré B, Djimdé A, Niangaly A, Kayentao K, Diallo M, Doumbo OK, Thera MA. Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali. Malaria Journal. 10: 345. PMID 22114867 DOI: 10.1186/1475-2875-10-345  0.4
2011 Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, et al. A field trial to assess a blood-stage malaria vaccine. The New England Journal of Medicine. 365: 1004-13. PMID 21916638 DOI: 10.1056/Nejmoa1008115  0.4
2010 Ouattara A, Mu J, Takala-Harrison S, Saye R, Sagara I, Dicko A, Niangaly A, Duan J, Ellis RD, Miller LH, Su XZ, Plowe CV, Doumbo OK. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malaria Journal. 9: 175. PMID 20565971 DOI: 10.1186/1475-2875-9-175  0.4
2010 Dolo A, Diallo M, Saye R, Konaré A, Ouattara A, Poudiougo B, Kouyaté B, Minta D, Doumbo OK. Obstacles to laboratory diagnosis of Malaria in Mali - Perspectives Medecine Tropicale. 70: 158-162. PMID 20486352  0.4
2009 Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Science Translational Medicine. 1: 2ra5. PMID 20165550 DOI: 10.1126/Scitranslmed.3000257  0.4
2008 Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, Diemert D, Long C, Zhou H, Miura K, Ouattara A, Dolo A, Doumbo O, Su XZ, Miller L. Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proceedings of the National Academy of Sciences of the United States of America. 105: 7857-62. PMID 18515425 DOI: 10.1073/Pnas.0802328105  0.4
2007 Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, Guindo AB, Kone AK, Traore K, Ouattara A, Djimde AA, Sehdev PS, Lyke KE, Diallo DA, Doumbo OK, Plowe CV. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. Plos Medicine. 4: e93. PMID 17355170 DOI: 10.1371/Journal.Pmed.0040093  0.4
2006 Gaudart J, Poudiougou B, Dicko A, Ranque S, Toure O, Sagara I, Diallo M, Diawara S, Ouattara A, Diakite M, Doumbo OK. Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village. Bmc Public Health. 6: 286. PMID 17118176 DOI: 10.1186/1471-2458-6-286  0.4
2006 Sagara I, Dicko A, Djimde A, Guindo O, Kone M, Tolo Y, Thera MA, Sogoba M, Fofana M, Ouattara A, Sissoko M, Jansen HF, Doumbo OK. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. The American Journal of Tropical Medicine and Hygiene. 75: 630-6. PMID 17038684 DOI: 10.4269/Ajtmh.2006.75.630  0.4
2004 Djimdé AA, Dolo A, Ouattara A, Diakité S, Plowe CV, Doumbo OK. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. The Journal of Infectious Diseases. 190: 853-5. PMID 15272415 DOI: 10.1086/422758  0.4
1998 Dossou-Yovo J, Ouattara A, Doannio JMC, Diarrassouba S, Chauvancy G. Malaria in the wet Savannah region of Cote d'Ivoire Medecine Tropicale. 58: 51-56.  0.4
1994 Dossou-Yovo J, Ouattara A, Doannio JM, Riviere F, Chauvancy G, Meunier JY. Aspects of malaria in a village of the humid savannah of the Ivory Coast Medecine Tropicale. 54: 331-336. PMID 7746125  0.4
Show low-probability matches.